全球纳米生物反应器市场 – 行业趋势及 2030 年预测

纳米生物反应器市场分析及规模

个性化医疗需求的不断增长将对生物反应器行业动态产生重大影响。慢性病发病率的不断上升，促使人们对个性化医疗的最新发展有了更多的认识。制药行业生物反应器的增长、生物反应器的技术进步以及一次性生物反应器 (SUB) 和混合生物反应器的日益普及是当前生物反应器市场增长的主要因素。  

Data Bridge Market Research 分析了 2023-2030 年预测期内纳米生物反应器市场的增长率。在上述预测期内，纳米生物反应器市场的预期复合年增长率约为 8.50%。2022 年市场价值为 32.8 亿美元，到 2030 年将增长至 63 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

纳米生物反应器的市场范围和细分

Market Definition

Nano bioreactors are designed to make process development and small scale production of virus for vaccines or gene therapy easy and straightforward. These are vessels that have been designed and produced to offer an effective environment for enzymes or whole cells to transform biochemicals into products. In many of the cases, the inactivation of cells or sterilization is carried out in the bioreactor such as in water treatment.

Global Nano Bioreactor Market Dynamics

Drivers

• Increasing Use of Recombinant Proteins

Recombinant proteins molecule is estimated to increase the growth of the market. Recombinant proteins have evolved as a prominent tool in medical research combined with promising effects against pathogen antigens. They are widely used as therapeutic proteins and replacement therapies, particularly in cases of hormonally active substances such as insulin and growth factor.  Thus, this factor increase the market growth.

• Increasing Funding by Government Organizations

Growing investments in R&D activities leading to developing novel treatments for chronic ailments will boost the need for bioreactors at research firms. These initiatives are implemented globally to address the rising cases of diabetes, cancer, respiratory diseases, and cardiovascular disorders. Growing focus on drug development is anticipated to boost the demand for bioreactors at R&D organizations.

Opportunities

• Rising Adoption Of Single-Use Bioreactors Due To Growing Infections

Single-use bioreactors are widely used in R&D and the production of novel vaccines. With the development of new infectious diseases such as COVID-19, numerous pharma companies have increased the adoption of these technologies. Numerous end-users are converting to single-use products because of advantages such as flexible process flow, cost-effectiveness, and lower cost of the material. Numerous advancements in miniaturized single-use bioreactors are further allowing R&D organizations to assuring cost efficiency. Thus, this factor significantly increases the market growth.

• Growing Use of Hybrid Bioreactor Technology

The wide use of hybrid bioreactor technology in effective waste management has increased the expansion of the market. Several initiatives by major market players are also boosting the market growth. For instance, Beckman Coulter Life Sciences launched its next-generation Biolector XT Microbioreactor in Germany in May 2021. The BioLector XT Microbioreactor enables high-throughput strain screenings, cultivation parameter monitoring, and feeding strategy optimization.​ Thus, this increasing expenditure will increase the growth rate.

 Restraints/Challenges

• Limited Space of Bioreactors  

The biggest disadvantage of nanobioreactors lies in its scaling. Large, flat rocker bioreactors do not scale well. They usually vary from only 5 to 100 L, with their size restricted by the rate of oxygen transfer through the headspace. Thus, this restraint hinders the usage of nanobioreactors by market players and organizations.

This nano bioreactor market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nano bioreactor market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2022, Getinge AB announced that their bioreactors will support the Dutch government's initiative to manufacture animal products such as meat and milk proteins directly from animal and microbial cells.

Global Nano Bioreactor Market Scope

The nano bioreactor market is segmented on the basis of material, cell, usage, molecule, control type, technology and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Material

• Glass
• Stainless Steel
• Single-Use

Cell

• Mammalian Cells
• Bacterial Cells
• Yeast Cells

Usage

• Lab-Scale Production
• Pilot-Scale Production
• Full-Scale Production

Molecule

• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Stem Cells
• Gene Therapy

Control Type

• Manual
• Automated (MFCs)

Technology

• Wave-Induced Motion SUB
• Stirred SUB
• Single-Use Bubble Column

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Nano Bioreactor Market Regional Analysis/Insights

The nano bioreactor market is analyzed and market size insights and trends are provided by material, cell, usage, molecule, control type, technology and end-user as referenced above.

The major countries covered in the nano bioreactor market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for nano bioreactor market throughout the forecast period because of the numerous strategies, such as mergers and acquisitions research and development and product launches. Furthermore, the increasing demand for biopharmaceutical products in the region and the focus on increasing localized production are anticipated to have a major impact on the market during the forecast period.

North America dominates the market due to the increase in collaboration among the industry and academic institutions. The U.S. holds the majority of the market in the North American region as pharmaceuticals and other hi-tech product makers have announced multimillion-dollar investments to expand manufacturing capabilities.  

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Nano Bioreactor Market Share Analysis

纳米生物反应器市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司关注的纳米生物反应器市场有关。

纳米生物反应器市场的主要参与者包括：

• Sartorius AG（德国）
• 赛默飞世尔科技（美国）
• 通用电气（美国）
• Eppendorf AG（德国）
• 默克集团（德国）
• Pall 公司 (美国)
• ZETA（印度）
• 皮埃尔·盖兰（法国）
• PRaj Hipurity Systems Limited（印度）
• Bioengineering AG（瑞士）
• Infors AG（瑞士）
• Solaris Biotechnology Srl.（意大利）
• Bbi Biotech（德国）
• 百伦生物技术股份有限公司 (中国)
• PBS Biotech Inc.（美国）
• CerCell A/S（丹麦）
• GEA 集团股份公司（德国）

SKU-55120